Peptides International's NEW Products for Summer and Fall 2018

A comprehensive list of all recently released product and prices

Diabetes Research Products - NEWLY UPDATED!

Diabetes is a prevalent disease, affecting approximately 30.3 million Americans (9.4% of the population).

A Practical Diastereoselective Synthesis of (−)‐Bestatin

J Pep Sci. 2018; e3067.

Neuropeptides for Alzheimer's Disease Research - NEWLY UPDATED!

A Quick Reference Brochure Listing Peptides International's Neuropeptides for Alzheimer's Disease Research

Parkinson's Disease Research Products Brochure - NEW!

A Quick Reference Brochure Listing Peptides International's Neuropeptides for PD Research

Enantioselective Synthesis of Fmoc-l-3-(2-Benzothienyl)Alanine (2-BtAla) via Diastereoselective Alkylation of a Glycine Equivalent

Tetrahedron Letters, (2017). [Accepted manuscript] Retrieved from http://www.sciencedirect.com/science/article/pii/S0040403917312819?via%3Dihub#f0025

Peptide Therapeutics From Venom: Current Status and Potential

Bioorganic & Medicinal Chemistry. Available online 23 September 2017, In Press, Accepted Manuscript

A Systems Pharmacology-Based Approach to Identify Novel Kv1.3 Channel-Dependent Mechanisms in Microglial Activation

J Neuroinflammation. 2017 Jun 26;14(1):128. doi: 10.1186/s12974-017-0906-6

Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK

Mar Drugs. 2015 Jan 16;13(1):529-42. doi: 10.3390/md13010529.

Distribution and Kinetics of the Kv1.3-Blocking Peptide HsTX1[R14A] in Experimental Rats

Sci Rep., 7, Article number: 3756 (2017).